Apellis Pharmaceuticals, Inc.
(NASDAQ: APLS)

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

23.325

+1.135 (+5.11%)
Range 22.015 - 23.380   (6.20%)
Open 22.130
Previous Close 22.190
Bid Price 82.290
Bid Volume 8
Ask Price 86.510
Ask Volume 8
Volume 423,757
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:06.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis